» Articles » PMID: 35453202

A Review: Antimicrobial Therapy for Human Pythiosis

Overview
Specialty Pharmacology
Date 2022 Apr 23
PMID 35453202
Authors
Affiliations
Soon will be listed here.
Abstract

Human pythiosis is associated with poor prognosis with significant mortality caused by . Antimicrobials' and results against . are inconsistent. Although antimicrobials are clinically useful, they are not likely to achieve therapeutic success alone without surgery and immunotherapy. New therapeutic options are therefore needed. This non-exhaustive review discusses the rationale antimicrobial therapy, minimum inhibitory concentrations, and efficacy of antibacterial and antifungal agents against . This review further provides insight into the immunomodulating effects of antimicrobials that can enhance the immune response to infections. Current data support using antimicrobial combination therapy for the pharmacotherapeutic management of human pythiosis. Also, the success or failure of antimicrobial treatment in human pythiosis might depend on the immunomodulatory effects of drugs. The repurposing of existing drugs is a safe strategy for anti- drug discovery. To improve patient outcomes in pythiosis, we suggest further research and a deeper understanding of virulence factors, host immune response, and host immune system modification by antimicrobials.

Citing Articles

Development of lateral flow immunochromatographic assay with Anti-Pythium insidiosum antibodies for point-of-care testing of vascular pythiosis.

Tongchai P, Burassakarn A, Langsiri N, Worasilchai N, Chindamporn A Sci Rep. 2025; 15(1):781.

PMID: 39755905 PMC: 11700136. DOI: 10.1038/s41598-024-84833-y.


Anti-Pythium insidiosum activity of three novel triazole compounds: synthesis, pharmacokinetic and toxicological parameters.

Fernandes C, Prestes A, Ianiski L, Maciel A, Noro B, da Silva F Braz J Microbiol. 2024; 56(1):331-340.

PMID: 39666162 PMC: 11885195. DOI: 10.1007/s42770-024-01572-y.


Treating Pythiosis with Antibacterial Drugs Targeting Protein Synthesis: An Overview.

Loreto E, Tondolo J, Zanette R J Fungi (Basel). 2024; 10(4).

PMID: 38667905 PMC: 11051233. DOI: 10.3390/jof10040234.


Pythiosis presenting with chronic swelling and painful subcutaneous lesion at right deltoid.

Luangnara A, Chuamanochan M, Chiewchanvit S, Pattamapaspong N, Salee P, Chaiwarith R IDCases. 2023; 33:e01873.

PMID: 37637497 PMC: 10448011. DOI: 10.1016/j.idcr.2023.e01873.


Outcomes of Pythium keratitis: a meta-analysis of individual patient data.

Cao B, Gonugunta V, Radhakrishnan N, Lalitha P, Gurnani B, Kaur K Curr Ophthalmol Rep. 2023; 10(4):198-208.

PMID: 37250102 PMC: 10211475. DOI: 10.1007/s40135-022-00302-7.


References
1.
Permpalung N, Worasilchai N, Manothummetha K, Torvorapanit P, Ratanawongphaibul K, Chuleerarux N . Clinical outcomes in ocular pythiosis patients treated with a combination therapy protocol in Thailand: A prospective study. Med Mycol. 2019; 57(8):923-928. DOI: 10.1093/mmy/myz013. View

2.
Polak A . Preclinical data and mode of action of amorolfine. Clin Exp Dermatol. 1992; 17 Suppl 1:8-12. DOI: 10.1111/j.1365-2230.1992.tb00270.x. View

3.
Cheng Y, Williamson P, Zheng W . Improving therapy of severe infections through drug repurposing of synergistic combinations. Curr Opin Pharmacol. 2019; 48:92-98. PMC: 6858965. DOI: 10.1016/j.coph.2019.07.006. View

4.
Keeratijarut A, Lohnoo T, Rujirawat T, Yingyong W, Kalambaheti T, Miller S . The Immunoreactive Exo-1,3-β-Glucanase from the Pathogenic Oomycete Pythium insidiosum Is Temperature Regulated and Exhibits Glycoside Hydrolase Activity. PLoS One. 2015; 10(8):e0135239. PMC: 4532416. DOI: 10.1371/journal.pone.0135239. View

5.
Majumdar S, Dutta K, Manna S, Basu A, Bishayi B . Possible protective role of chloramphenicol in TSST-1 and coagulase-positive Staphylococcus aureus-induced septic arthritis with altered levels of inflammatory mediators. Inflammation. 2010; 34(4):269-82. DOI: 10.1007/s10753-010-9233-0. View